Oxford Cannabinoid Technologies Holdings (FRA:0CB) Debt-to-Equity : 0.00 (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Debt-to-Equity?

Oxford Cannabinoid Technologies Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was €0.00 Mil. Oxford Cannabinoid Technologies Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was €0.00 Mil. Oxford Cannabinoid Technologies Holdings's Total Stockholders Equity for the quarter that ended in Oct. 2023 was €2.25 Mil. Oxford Cannabinoid Technologies Holdings's debt to equity for the quarter that ended in Oct. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Debt-to-Equity or its related term are showing as below:

During the past 5 years, the highest Debt-to-Equity Ratio of Oxford Cannabinoid Technologies Holdings was 0.18. The lowest was 0.00. And the median was 0.01.

FRA:0CB's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.14
* Ranked among companies with meaningful Debt-to-Equity only.

Oxford Cannabinoid Technologies Holdings Debt-to-Equity Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Debt-to-Equity Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

Debt-to-Equity

0.18

0.01

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
Debt-to-Equity	Get a 7-Day Free Trial				0.01	-	-	-	-

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Debt-to-Equity

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Cannabinoid Technologies Holdings's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Debt-to-Equity falls into.

Oxford Cannabinoid Technologies Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Oxford Cannabinoid Technologies Holdings's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	4.443
	=	0.00

Oxford Cannabinoid Technologies Holdings's Debt to Equity Ratio for the quarter that ended in Oct. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	2.249
	=	0.00

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Oxford Cannabinoid Technologies Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

OCTP:UK

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines